Lucid Diagnostics (LUCD) News Today → Wall Street Legend Issues New NVDA Warning (From Chaikin Analytics) (Ad) Free LUCD Stock Alerts $0.64 -0.04 (-6.31%) (As of 10:45 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLucid Diagnostics Inc. Common Stock (LUCD)nasdaq.com - April 21 at 12:28 PM3 Penny Stocks That Could Make a Big Comeback by the End of Q2investorplace.com - April 19 at 6:00 AMLucid Diagnostics: Strong Buy Rating with Significant Market Potential Despite Near-Term Lossesmarkets.businessinsider.com - April 15 at 12:56 PMBuy Rating Affirmed for Lucid Diagnostics Amidst Strong EsoGuard Testing Growth and Clear Reimbursement Pathmarkets.businessinsider.com - April 12 at 2:36 PMAnalysts Are Bullish on Top Healthcare Stocks: Lucid Diagnostics (LUCD), Werewolf Therapeutics (HOWL)markets.businessinsider.com - April 10 at 6:42 PMLucid Diagnostics holds Buy rating, and stock target on company's performanceinvesting.com - April 10 at 1:42 PMLucid Diagnostics Inc. (LUCD) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 28 at 6:03 PMBuy Rating for Lucid Diagnostics: Solid Test Volumes and Strategic Growth Initiatives Propel Market Positionmarkets.businessinsider.com - March 28 at 6:03 PMPAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 28 at 1:02 PMBuy Rating Affirmed for Lucid Diagnostics Amid Strong Financials and Strategic Growth Initiativesmarkets.businessinsider.com - March 28 at 2:00 AMPAVmed Inc.: PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 27 at 9:00 PMBuy Rating Affirmed for Lucid Diagnostics Amidst Growing Test Volume and Strategic Positioning for Medicare Reimbursementmarkets.businessinsider.com - March 27 at 9:00 PMLucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 27 at 3:59 PMQ4 2023 Lucid Diagnostics Inc Earnings Callfinance.yahoo.com - March 27 at 10:58 AMLUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 25 at 11:35 PMLucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - March 25 at 7:24 PMLucid Diagnostics Gets Positive Data From Clinical Validation Study Of EsoGuard Esophageal DNA Testmarkets.businessinsider.com - March 21 at 6:24 PMLucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Populationprnewswire.com - March 21 at 9:30 AMLucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conferencefinance.yahoo.com - March 20 at 5:39 PMLucid Diagnostics (LUCD) to Release Earnings on Tuesdaymarketbeat.com - March 11 at 7:39 AMLucid Diagnostics target oesphageal cancer with early testingmsn.com - February 21 at 1:29 PMLucid Diagnostics Provides Update Regarding World Trade Center Health Programprnewswire.com - February 16 at 5:00 PMLucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Up 16.4% in Januarymarketbeat.com - February 16 at 11:54 AMLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimonyfinance.yahoo.com - February 15 at 10:02 AMLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimonyprnewswire.com - February 15 at 7:45 AMLucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivorsfinanznachrichten.de - February 8 at 12:21 PMLucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Updatemarketbeat.com - January 30 at 11:31 AMLucid Diagnostics Stock (NASDAQ:LUCD) Dividends: History, Yield and Datesbenzinga.com - December 30 at 1:17 AMThe 3 Most Undervalued Penny Stocks to Buy in Decemberfinance.yahoo.com - December 25 at 10:15 AMNeedham reiterates Buy on Lucid Diagnostics following investor dayza.investing.com - December 14 at 10:36 AMLucid Diagnostics Inc LUCDmorningstar.com - December 12 at 9:45 PMLucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studiesfinance.yahoo.com - December 12 at 8:46 AMLucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 16 at 12:52 PMLucid Diagnostics Non-GAAP EPS of -$0.22 in-line, revenue of $0.8M beats by $0.01Mmsn.com - November 14 at 1:58 AMEarnings Preview For Lucid Diagnosticsbenzinga.com - November 10 at 3:17 PMElucid closes $80m Series C for AI cardiovascular risk diagnostic toolmsn.com - November 9 at 6:43 PMLucid Diagnostics to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services Forumfinance.yahoo.com - November 2 at 1:34 PMPAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023finance.yahoo.com - November 1 at 9:47 AMLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2023finance.yahoo.com - October 31 at 12:57 PMLucid Diagnostics Announces PREVENT and PREVENT-FF Registries of EsoGuard® Esophageal Precancer Detectionfinance.yahoo.com - October 31 at 12:57 PMPAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conferencefinance.yahoo.com - September 21 at 8:52 AMU.S. electric carmaker Lucid is exploring China entry; confirms mass market models aheadcnbc.com - September 11 at 5:07 PMLucid Diagnostics Executes First Direct Employer Contract to Provide EsoGuard® Esophageal Precancer Testing as an Employee Benefitfinance.yahoo.com - August 24 at 6:01 PMPAVmed Inc.: PAVmed Provides Business Update and Second Quarter Financial Resultsfinanznachrichten.de - August 16 at 6:36 AMQ2 2023 Lucid Diagnostics Inc Earnings Callfinance.yahoo.com - August 16 at 1:36 AMPAVmed Provides Business Update and Second Quarter Financial Resultsfinance.yahoo.com - August 15 at 8:35 PMI drove the $180,000 Lucid Air and saw why it's one of the most impressive Tesla rivals yetbusinessinsider.com - August 12 at 9:41 AMLucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 15, 2023finance.yahoo.com - July 31 at 8:50 PMPAVmed to Hold a Business Update Conference Call and Webcast on August 16, 2023finance.yahoo.com - July 31 at 8:50 PMLucid Diagnostics Inc.thestreet.com - July 29 at 12:19 PM Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street Legend Issues New NVDA Warning (Ad)Legendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock. Click here for the stock details LUCD Media Mentions By Week LUCD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUCD News Sentiment▼-0.500.44▲Average Medical News Sentiment LUCD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUCD Articles This Week▼31▲LUCD Articles Average Week Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ICU News CODX News CTCX News CTSO News DRIO News MDAI News LNSR News MODD News RVP News XAIR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUCD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWall Street Legend Issues New NVDA WarningChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternativetop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
